Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Gains from Investment Securities (2016 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Gains from Investment Securities for 15 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 73.87% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Dec 2025, up 24.2% year-over-year, with the annual reading at $6.6 million for FY2025, 24.2% up from the prior year.
  • Gains from Investment Securities hit $1.4 million in Q4 2025 for Ani Pharmaceuticals, down from $5.2 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $5.3 million in Q1 2024 to a low of -$5.3 million in Q3 2024.
  • Historically, Gains from Investment Securities has averaged $1.2 million across 5 years, with a median of $750000.0 in 2021.
  • Biggest YoY gain for Gains from Investment Securities was 12059.46% in 2023; the steepest drop was 722.27% in 2023.
  • Year by year, Gains from Investment Securities stood at $241000.0 in 2021, then surged by 200.0% to $723000.0 in 2022, then crashed by 722.27% to -$4.5 million in 2023, then skyrocketed by 218.85% to $5.3 million in 2024, then crashed by 73.87% to $1.4 million in 2025.
  • Business Quant data shows Gains from Investment Securities for ANIP at $1.4 million in Q4 2025, $5.2 million in Q3 2025, and $5.3 million in Q4 2024.